GB1569486A - Racemisationof 6-oxo-2-piperidine-carboxylic acid entantiomers - Google Patents

Racemisationof 6-oxo-2-piperidine-carboxylic acid entantiomers Download PDF

Info

Publication number
GB1569486A
GB1569486A GB5229477A GB5229477A GB1569486A GB 1569486 A GB1569486 A GB 1569486A GB 5229477 A GB5229477 A GB 5229477A GB 5229477 A GB5229477 A GB 5229477A GB 1569486 A GB1569486 A GB 1569486A
Authority
GB
United Kingdom
Prior art keywords
hpca
residue
filter
water
wash
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5229477A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1569486A publication Critical patent/GB1569486A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Description

(54) RACEMIZATION OF 6-OXO-2-PIPERIDINE-CARBOXYLIC ACID ENANTIOMERS (71) We, MERCK & CO. INC., a corporation duly organized and existing under the laws of the State of New Jersey, United States of America, of Rahway, New Jersey, United States of America, do hereby declare the invention for which we pray that a patent may be granted to us and the method by which it is to be performed to be particularly described in and by the following statement: The present invention is concerned with racemization of an enantiomer of 6-oxo-2piperidine carboxylic acid.
Racemic-d, 1-6-oxo-2-piperidine carboxylic acid may be separated into its individual isomers (entantiomers) by direct resolution using quinine as the resolving agent. This process is described and claimed in the specification of our copending Application No.
52292/77 (Serial No. 1569485). Whether the 1- or d-isomer is the desired product, the other isomer is necessarily a yield-lowering (50%) by-product. It is advantageous if the undesired by-product enantiomer can be racemized for recycling in the resolution process.
A straightforward process for racemizing the enantiomers of 6-oxo-2-piperidine carboxylic acid has now been discovered and the present invention provides a method of racemizing an enantiomer of 6-oxo-2-piperidine carboxylic acid by heating it to a temperature substantially above its melting point in an inert atmosphere.
6-Oxo-2-piperidine carboxylic acid has the formula:
It is also referred to as homopyrrolidonecarboxylic acid (HPCA).
The preferred racemization temperature for the d-isomer is not less than 205"C, particularly in the range 205C - 250"C. The time required to effect complete racemization is ;dependent on the temperature at which the enantiomer is heated; a longer time being required at a lower temperature and vice versa.
The inert atmosphere can be, for example, nitrogen or helium.
The individual isomers as well as the racemate are useful for preparing tripeptides described in U.S. 3,959,248.
Following are examples illustrating the resolution of d, 1-6-oxo-2-piperidine carboxylic -acid (HPCA), the racemization of the d-enantiomer for recycling to the resolution and the racemization of l-enantiomer. All temperatures are in "C unless otherwise indicated.
Example I A. Preparation of d-HPCA quinine salt Dissolve 2.27 g of anhydrous quinine in 208 ml of acetonitrile with warming and add a suspension of 1 g of dl-HPCA in 180 ml of warm acetonitrile. Seed with the quinine salt of d-HPCA and allow to crystallize at room temperature. When crystallization is complete, filter and wash with two 5-ml portions of acetonitrile and air dry the precipitate. The yield is 1.71 g, mp 213.5-215.5 dec.
B. Preparation of l-HPCA quinine salt Concentrate the combined mother liquors and wash from the previous step to 25 ml, add 0.25 ml of water and seed with the quinine salt of l-HPCA. Allow to crystallize at room temperature. Filter and wash with two 3-ml portions of acetonitrile and air dry the precipitate. The yield is 1.19 g of solvated product, mp 180-183 .
To purify, disperse 1 g in 67 ml of acetonitrile containing 1% water warmed to 39 and filter the solution from a trace of insoluble material. Concentrate the filtrate to 11.5 ml, seed with l-HPCA quinine salt and allow to crystallize at room temperature. Filter and wash with three 2-ml portions of acetonitrile and air dry the precipitate. The yield is 0.8759g. Mp 159-160"C, resolidifying and remelting at 182-184". The material may be desolvated by heating in vacuo at 1000. The rotation (dry basis) [a]2l = -140.2", C = 2 in 6N HC1.
C. Preparation of l-HPCA Dissolve 0.6495 g of 1-HPCA quinine salt in 19.5 ml of water and make the solution alkaline with 1 ml of 2.5N NaOH. Filter the precipitated quinine after it becomes granular.
Acidify the filtrate with 0.85 ml of 2.5N HC1 and evaporate to a residue. Extract the residue with anhydrous ethanol and concentrate the extract to a residue. Dissolve the residue in a small amount of water and allow the l-HPCA to crystallize. Filter and wash with water, and vacuum dry at room temperature. The yield is 0.1306 g of partially solvated material. [a] = +35.3 , C = 2 in 6N HC1 or +39.0 corrected for solvation.
Example 2 A. Preparation of d-HPCA Dissolve 22.21 g. of crude d-HPCA quinine salt in 30 parts of water and make the solution alkaline with 60 ml of 2.5N NaOH. Filter off the precipitated quinine after it becomes granular. Acidify the filtrate with 15 ml of conc. HC1 and concentrate the solution to a residue. Extract the residue, portionwise, with a total of 125 ml of boiling absolute ethanol and concentrate the extracts to a residue. Dissolve the residue in 9 ml of water and allow to crystallize. Filter off the precipitated hydrate of d-HPCA, wash with 2 ml of water and air dry. The yield is 1.87 g. Crop I. Obtain a further crop by concentration of the mother liquors, and additional material by known chromatographic procedures for a total of 4.09 g.
B. Racemization of d-HPCA Heat 100 mg of the d-HPCA obtained as above under a slow stream of nitrogen in an oil bath (250 ) four minutes and cool to a glass. Triturate the residue under ethanol until the glass changes to a flocculent precipitate. Remove the ethanol in vacuo to obtain a residue of dl-HPCA, [cr]D = 0.00, m.p. 160-172", IR matching that of anhydrous d-HPCA.
C. Racemization of l-HPCA l-HPCA is racemized using substantially the same procedure as used for racemizing d-HPCA.
WHAT WE CLAIM IS: 1. A method of racemizing an enantiomer of 6-oxo-2-piperidine carboxylic acid that comprises heating the enantiomer to a temperature substantially above its melting point in an inert atmosphere.
2. A method as claimed in Claim 1, in which the enantiomer is the d-isomer and the temperature is above 205"C.
3. A method as claimed in Claim 2, in which the temperature is 205 C to 250 C.
4. A method as claimed in Claim 1, in which the enantiomer is the l-isomer.
5. A method as claimed in Claim 1, substantially as hereinbefore described in Example 2.
**WARNING** end of DESC field may overlap start of CLMS **.

Claims (5)

**WARNING** start of CLMS field may overlap end of DESC **. suspension of 1 g of dl-HPCA in 180 ml of warm acetonitrile. Seed with the quinine salt of d-HPCA and allow to crystallize at room temperature. When crystallization is complete, filter and wash with two 5-ml portions of acetonitrile and air dry the precipitate. The yield is 1.71 g, mp 213.5-215.5 dec. B. Preparation of l-HPCA quinine salt Concentrate the combined mother liquors and wash from the previous step to 25 ml, add 0.25 ml of water and seed with the quinine salt of l-HPCA. Allow to crystallize at room temperature. Filter and wash with two 3-ml portions of acetonitrile and air dry the precipitate. The yield is 1.19 g of solvated product, mp 180-183 . To purify, disperse 1 g in 67 ml of acetonitrile containing 1% water warmed to 39 and filter the solution from a trace of insoluble material. Concentrate the filtrate to 11.5 ml, seed with l-HPCA quinine salt and allow to crystallize at room temperature. Filter and wash with three 2-ml portions of acetonitrile and air dry the precipitate. The yield is 0.8759g. Mp 159-160"C, resolidifying and remelting at 182-184". The material may be desolvated by heating in vacuo at 1000. The rotation (dry basis) [a]2l = -140.2", C = 2 in 6N HC1. C. Preparation of l-HPCA Dissolve 0.6495 g of 1-HPCA quinine salt in 19.5 ml of water and make the solution alkaline with 1 ml of 2.5N NaOH. Filter the precipitated quinine after it becomes granular. Acidify the filtrate with 0.85 ml of 2.5N HC1 and evaporate to a residue. Extract the residue with anhydrous ethanol and concentrate the extract to a residue. Dissolve the residue in a small amount of water and allow the l-HPCA to crystallize. Filter and wash with water, and vacuum dry at room temperature. The yield is 0.1306 g of partially solvated material. [a] = +35.3 , C = 2 in 6N HC1 or +39.0 corrected for solvation. Example 2 A. Preparation of d-HPCA Dissolve 22.21 g. of crude d-HPCA quinine salt in 30 parts of water and make the solution alkaline with 60 ml of 2.5N NaOH. Filter off the precipitated quinine after it becomes granular. Acidify the filtrate with 15 ml of conc. HC1 and concentrate the solution to a residue. Extract the residue, portionwise, with a total of 125 ml of boiling absolute ethanol and concentrate the extracts to a residue. Dissolve the residue in 9 ml of water and allow to crystallize. Filter off the precipitated hydrate of d-HPCA, wash with 2 ml of water and air dry. The yield is 1.87 g. Crop I. Obtain a further crop by concentration of the mother liquors, and additional material by known chromatographic procedures for a total of 4.09 g. B. Racemization of d-HPCA Heat 100 mg of the d-HPCA obtained as above under a slow stream of nitrogen in an oil bath (250 ) four minutes and cool to a glass. Triturate the residue under ethanol until the glass changes to a flocculent precipitate. Remove the ethanol in vacuo to obtain a residue of dl-HPCA, [cr]D = 0.00, m.p. 160-172", IR matching that of anhydrous d-HPCA. C. Racemization of l-HPCA l-HPCA is racemized using substantially the same procedure as used for racemizing d-HPCA. WHAT WE CLAIM IS:
1. A method of racemizing an enantiomer of 6-oxo-2-piperidine carboxylic acid that comprises heating the enantiomer to a temperature substantially above its melting point in an inert atmosphere.
2. A method as claimed in Claim 1, in which the enantiomer is the d-isomer and the temperature is above 205"C.
3. A method as claimed in Claim 2, in which the temperature is 205 C to 250 C.
4. A method as claimed in Claim 1, in which the enantiomer is the l-isomer.
5. A method as claimed in Claim 1, substantially as hereinbefore described in Example 2.
GB5229477A 1976-12-22 1977-12-15 Racemisationof 6-oxo-2-piperidine-carboxylic acid entantiomers Expired GB1569486A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75293476A 1976-12-22 1976-12-22

Publications (1)

Publication Number Publication Date
GB1569486A true GB1569486A (en) 1980-06-18

Family

ID=25028488

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5229477A Expired GB1569486A (en) 1976-12-22 1977-12-15 Racemisationof 6-oxo-2-piperidine-carboxylic acid entantiomers

Country Status (2)

Country Link
GB (1) GB1569486A (en)
IE (1) IE46223B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115679A1 (en) * 1982-12-20 1984-08-15 Imperial Chemical Industries Plc Chemical process
US4567278A (en) * 1984-03-26 1986-01-28 Imperial Chemical Industries Plc Process for racemizing certain spiro compounds
EP1067129A1 (en) * 1999-07-06 2001-01-10 Bayer Ag Racemisation of R,S-dioxo-benzylpyrrolopipieridine

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115679A1 (en) * 1982-12-20 1984-08-15 Imperial Chemical Industries Plc Chemical process
US4567278A (en) * 1984-03-26 1986-01-28 Imperial Chemical Industries Plc Process for racemizing certain spiro compounds
EP1067129A1 (en) * 1999-07-06 2001-01-10 Bayer Ag Racemisation of R,S-dioxo-benzylpyrrolopipieridine
US6392044B1 (en) 1999-07-06 2002-05-21 Bayer Aktiengesellschaft Racemization of R,S-dioxo-benzylpyrrolopiperidine

Also Published As

Publication number Publication date
IE46223B1 (en) 1983-04-06
IE46223L (en) 1978-06-22

Similar Documents

Publication Publication Date Title
EP0007116B1 (en) Method for resolving racemic 6-methoxy-alpha-methyl-2-naphthalene acetic acid into its enantiomers and resolving medium
JP4298212B2 (en) Method for producing high melting point type epinastine hydrochloride
US4198524A (en) Optically active amino acid-mandelic acid complexes
US4016205A (en) Process for the optical resolution of DL-2-(4-hydroxyphenyl)glycine
US3991077A (en) Method of racemizing optically active N-acylamino acids
GB1569486A (en) Racemisationof 6-oxo-2-piperidine-carboxylic acid entantiomers
EP0173921B1 (en) Process for the racemization of an alpha-amino acid
US4399284A (en) Process for the optical resolution of mixtures of D- and L-2-(6-methoxy-2-naphthyl)-propionic acids
Behr et al. lp-METHOXYPHENYLALANINE1
US3994962A (en) Method of manufacturing optically active p-hydroxyphenylglycine
US3857889A (en) Isolation process
US5292933A (en) Process for the resolution of threo-3-[(2-aminophenyl)-thio]-2-hydroxy-3-(4-methoxy-phenyl)propionic acid
EP0133053B1 (en) Process for preparing optically active phenylalanine
US4161600A (en) Dextro and levo-6-oxo-2-piperidinecarboxylic acid quinine salts
US3925454A (en) Preparation of optically active isomers of lysines
EP0876329B1 (en) Process for the production of n-acetyl-d,l-alpha-aminocarboxylic acids
EP0171616B1 (en) The use of alpha-amino-epsilon-caprolactam as a resolving agent for n-acetylindoline-2-carboxylic acid and method for preparing optically active n-acetylindoline-2-carboxylic acid
US2846469A (en) Method of preparing synthetic dl-3 monoamide of 1-aminoglutaric acid (dl-glutamine)
US3932491A (en) Process for optical resolution of racemic lysine sulphanilate
US3798263A (en) Process for making dl-s-benzyl-n-acetyl cysteine
EP0050521A1 (en) Preparation of insecticidal optically active isovalerate esters
IL33109A (en) Process for the preparation of a salt of optically active lysine
US3658897A (en) Process for the preparation of optically active lysine
KR820001179B1 (en) Method for resolving racemic 6-methoxy-2 methyl-2-naphthalene acetic acid into its enantiomers
US5202435A (en) Process for the preparation of moricizine hydrochloride

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee